Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 449 across all filing types
Latest filing 2022-05-10 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Bio-Gene to Present at Bioshares 16th Biotech Summit 2 pages 251.5KB
Regulatory Filings
2022-05-10 English
Update on Development Program with BASF 1 page 237.
Regulatory Filings
2022-05-10 English
Appendix 4C - 31 March 2022 9 pages 445.0KB
Regulatory Filings
2022-04-26 English
Investor Presentation and Overview of Appendix 4C 1
Regulatory Filings
2022-04-26 English
Bio-Gene Executes Commercial Development Agreement 3 pages 264.7KB
Regulatory Filings
2022-04-03 English
Participation at Credit Suisse Asia Investor Conference 2 pages 271.4KB
Regulatory Filings
2022-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.